This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
SRP54 · Western blot design guide
SRP54 Western Blot Planning Guide
Plan a SRP54 Western blot around the catalog-observed 55.7 kDa band, image-backed A06189-1 evidence, HPA controls, and verified protocol records.
Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
SRP54 Western Blot Experimental Design Guide
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | 55.7 kDa | |
| Observed band | Not reported — verify product WB image | |
| Gel | 12-15% | |
| Positive control | Breast | |
| Negative control | Skeletal muscle |
Important caveats
Reasons your observed band may differ from the expected size.
| ⓘ | Calculated mass | 55.7 kDa |
| ⓘ | Localization | Nucleus speckle / Cytoplasm |
| ⓘ | Processing / PTM | Record-dependent |
| ⓘ | Reactivity | Human / Mouse / Rat |
Section 1
Real Curated SRP54 Western Blot Protocols
Start with the molecular-weight rule, then compare verified publication-derived conditions.
| Sample / lysate | Appendix |
| Gel % | 12-15% |
| Load | 20-30 µg total protein per lane |
| Transfer | Semi-dry, standard transfer |
| Membrane | 0.45 µm PVDF |
| Blocking | 5% non-fat milk or 5% BSA in TBST |
| Primary | A06189-1 at datasheet starting dilution |
| Primary incubation | Overnight at 4 °C with gentle agitation |
| Secondary | Species-matched HRP conjugate at validated dilution |
| Wash | 3 × 5 min in TBST |
| Detection | Chemiluminescent substrate |
| Exposure | Bracket exposures to avoid saturation |
Section 2
What Is the Expected SRP54 Western Blot Band Size?
Use the product-observed 55.7 kDa band as the primary planning value and retain the UniProt calculated mass as context.
| 55.7 kDa | Matches the authoritative product WB observation. |
| 55.7 kDa calculated | Use as UniProt context, not as a replacement observed band. |
| Unexpected additional signal | Do not assign identity without orthogonal positive/negative controls. |
💡Expected SRP54 appearancePlan around 55.7 kDa and keep the calculated mass as supporting context.
| Catalog-observed band | 55.7 kDa; use this as the primary experimental expectation. |
| Calculated mass | 55.7 kDa from UniProt P61011; retain as context. |
| Gel selection | 12-15%; shared with the recommended protocol and poster. |
| Specificity check | Compare the lead HPA positive and negative controls with A06189-1. |
| Situation | Likely cause | Next action |
|---|---|---|
| 55.7 kDa | Matches the authoritative product WB observation. | Confirm with orthogonal controls and the linked product record. |
| Additional band | May reflect processing, modification, or non-specific signal. | Run a dilution series and compare positive/negative controls. |
| Weak signal | Target abundance or transfer may be limiting. | Verify transfer, increase positive-control abundance, and bracket exposure. |
Experiment evidence
Western blot images showing SRP54 band
A06189-1 · SRP54
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for SRP54 Western blot
🧪Use Breast as the first positive-control candidate and Skeletal muscle as the HPA Not detected negative candidate.
Positive control: Breast (High)
Negative control: Skeletal muscle (Not detected)
HPA protein score determines control status; other expression data is supporting context only.
HPA tissue expression evidence for SRP54
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Breast | Reported tissue cells | High | Protein (HPA) | HPA → |
| Appendix | Reported tissue cells | High | Protein (HPA) | HPA → |
| Bronchus | Reported tissue cells | High | Protein (HPA) | HPA → |
| Cerebral cortex | Reported tissue cells | High | Protein (HPA) | HPA → |
Section 3
Advanced SRP54 Western Blot Tips
Deeper troubleshooting and optimisation questions for SRP54, answered from its protein features.
Which band should guide the blot?
Use 55.7 kDa, the observation attached to the authoritative A06189-1 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 55.7 kDa expectation.
Which positive control should I start with?
Start with Breast, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Skeletal muscle as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for SRP54 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A06189-1 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents
SRP54 Western Blot Reagents
Human/Mouse/Rat-reactive SRP54 Western blot reagents with authoritative product imagery.
Real WB data
Anti-SRP54 Antibody Picoband®
Cat # A06189-1
Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.
Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.
References
- UniProt P61011
- Human Protein Atlas — SRP54
- A06189-1 product record
- PMC2928861 — A ribosome-associating factor chaperones tail-anchored membrane proteins (Nature, 2010)
- PMC1948019 — Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions (Retrovirology, 2007)